Thanks Lykira, your posts are always some of the best. You are suggesting that perhaps improvements were made to DCVax from Germany. And Iam suggesting that the impovements may have been a colaberation between German hospital and Bosch from NWBO Anwyways I am surmising the home run we have been waiting for is data on the later enrolled patients. The reason why they had to run the trial out this long is because statistacily a small number were later enrolled with new method.
So hoping top line data reads out that trial was succesful in progression free survival.Trial was succesful in overall survival. The last 50 patients enrolled in trial have so far survived 30% longer than our initial patients that have significantly out performed standard of care. Good luck all believers
Lykiri/flipper et al., the link Lykiri posted on ICD that involves dead cells/apoptosis that becomes antigen cargo for DC vaccines while it subverts immunosuppressive environment is very interesting to note. Thanks to Dr. B, I think Direct is exactly designed based on this concept. Glad 5-ALA resection technique was used in the last several German patients in the L trial that provided tons more of antigen cargo to the autologus L vaccine already prepared. I now clearly understood this part of the L trial now. I think this portion of the L trial is used as Phase 4 to confirm the effectiveness of the therapy. We are sure good to go and the month of November will bring good fortune to all of us and of course good health for the cancer patients all over the world.
Market Data 
Markets 
AI
